Intrinsiqq
Silexion Therapeutics Corp. logo

Silexion Therapeutics Corp. Dividend Analysis

SLXN

Compare
Dividend0
No active dividend

This company has no dividend history.

Based on TTM and annual data · Not a buy/sell signal

This company does not pay dividends

No dividend history found in SEC filings.

Does Silexion Therapeutics (SLXN) pay a dividend?

Silexion Therapeutics (SLXN) has never paid a dividend. Free cash flow is currently negative, so there is no surplus to distribute. All figures are computed from company filings; this is analysis, not investment advice.

Frequently asked

Does Silexion Therapeutics (SLXN) pay a dividend?+

No. Silexion Therapeutics (SLXN) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.

How does Silexion Therapeutics return cash to shareholders?+

It largely does not. Silexion Therapeutics pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.

Could Silexion Therapeutics afford to pay a dividend?+

Not currently. Silexion Therapeutics's free cash flow is negative at -$12 million, meaning the business consumed cash over the period rather than generating it. A company funding a dividend from cash it is not producing would be paying shareholders out of its balance sheet or borrowings, which is not sustainable.

Which healthcare companies do pay dividends?+

Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Silexion Therapeutics.

SourceDividend analysis computed from the 10-Q filed 12 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 12 Nov 2026. How this is calculated.

Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with SLXN

CompareIntrinsic value
STROSutro Biopharma, Inc.
$8.60-1.38%10
AIMAIM ImmunoTech Inc.
$0.11-4.50%25
ARMPArmata Pharmaceuticals Inc.
$3.03+1.68%30
CRDFCardiff Oncology Inc.
$0.85-4.18%36
LCTXLineage Cell Therapeutics Inc.
$0.77-5.87%10
FDMT4D Molecular Therapeutics, Inc.
$10.23-4.57%40
PROKProKidney Corp
$1.04-1.89%10
FENCFennec Pharmaceuticals Inc.
$13.10-2.60%50

Spot a number that looks wrong? Check it in SLXN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing SLXN

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.